Opioids drive continued increase in drug overdose deaths

Similar documents
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science

Article #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention. Understanding the Epidemic

New Guidelines for Prescribing Opioids

Addressing the Opioid Epidemic in Tennessee

Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs --- United States,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

CDC s Efforts to End the Opioid Epidemic

High-Decile Prescribers: All Gain, No Pain?

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

PRESCRIBING GUIDELINES

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers

Michael M. Miller, MD, FASAM, FAPA

White Paper on. Prescription Drug Abuse

CDC s Approach to Addressing the Opioid Overdose Epidemic

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

A Different Kind of Drug War. CINDY SANDERS Posted: Thursday, April 5, :07 pm. Providers Focus on Prescription Drug Addiction, Abuse

Key points. o Potential for nonmedical use, abuse, and diversion of new products

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

A National Perspective on the Abuse and Diversion of Prescription Drugs

OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know

The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH 6/30/2017

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016

What is the strategy?

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Concepts to Action: Addressing a Public Health Epidemic. Adam Seidner MD MPH CIC

Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Rising Threats in the Nation s Drug Epidemic

The Prescription Drug Overdose Epidemic

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

University of Pittsburgh

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Pennsylvania Prescription Drug Monitoring Program Trends,

Prescription Opioid Policies (22 March 2016)

Opioid Abuse. in Rural Minnesota. County Farm Bureau Resource Guide

Top 10 narcotic pain pills

Opioid Use and Other Trends

Medication Misuse and Abuse: A Growing Epidemic

Drug-Related Deaths in Yolo County,

Ron Morton, M.A. Director of Recovery and Resiliency ValueOptions Tennessee

Prescription Opioid Overdose in Oregon: A public health perspective

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Opioid Overdose in Oregon Report to the Legislature

Arkansas Prescription Monitoring Program

Abuse, Misuse, and Diversion of Prescription Opioids: Evaluating the Problem and Proposed Solutions

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

As a self-insured employer, one of your biggest challenges and potentially one of the

North Carolina, like the rest of the nation, has been experiencing

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Medicare Part D Opioid Policies for 2019 Information for Patients

Prescription Drug Monitoring Programs and Other State-Level Strategies

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

How serious is the opiate problem in Fairfield County?

Delaware Emergency Department Opioid Prescribing Guidelines

The Difficult Patient: Risk Mitigation Strategies

Aligning Market Objectives and Policy for National Public Health

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Prescription Drug Abuse National Perspective

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

Dangerous Liaisons. Overdose, Diversion & Deception

A nation in pain: Focus on Medicaid

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

PREVENTION. Carroll County Health Department. Bureau of Prevention, Wellness and Recovery

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

Do your Part Be the Solution

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

Managed Care Pushes for Safer Opioid Oversight

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Epidemiologic Data on Opioid Use: Changing Problems

Opioid Addiction Statistics

Understanding and Combating the Heroin Epidemic

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Michigan Legislative and Regulatory Pharmacy Initiatives Update

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Introduction. Introduction. Demonstration of an Effective Post-Op Pain Management Protocol In Distal Radius Fractures

5/16/2016. Roadmap. Legal Competencies. Prescription Drug Overdose at Epidemic Levels

Challenges in Conducting Postmarketing Abuse Investigations

Popping Pills for Thrills Implications for preventing the misuse of pharmaceuticals

Responding to the Opioid Addiction Epidemic

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

<ctrl> <click> Here to the start the sound.

Transcription:

CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th consecutive year in 2010, according to an analysis from the Centers for Disease Control and Prevention. The findings are published today in a research letter, Pharmaceutical Overdose Deaths, United States, 2010, in the Journal of the American Medical Association (JAMA). CDC s analysis shows that 38,329 people died from a drug overdose in the United States in 2010, up from 37,004 deaths in 2009. This continues the steady rise in overdose deaths seen over the past 11 years, starting with 16,849 deaths in 1999. Overdose deaths involving opioid analgesics have shown a similar increase. Starting with 4,030 deaths in 1999, the number of deaths increased to 15,597 in 2009 and 16,651 in 2010. 1 / 5

In 2010, nearly 60 percent of the drug overdose deaths (22,134) involved pharmaceutical drugs. Opioid analgesics, such as oxycodone, hydrocodone, and methadone, were involved in about 3 of every 4 pharmaceutical overdose deaths (16,651), confirming the predominant role opioid analgesics play in drug overdose deaths. CDC researchers analyzed data from CDC s National Center for Health Statistics 2010 multiple cause-of-death file, which is based on death certificates. The researchers also found that drugs often prescribed for mental health conditions were involved in a significant number of pharmaceutical overdose deaths. Benzodiazepines (anti-anxiety drugs) were involved in nearly 30 percent (6,497) of these deaths; antidepressants in 18 percent (3,889), and antipsychotic drugs in 6 percent (1,351). Deaths involving more than one drug or drug class are counted multiple times and therefore are not mutually exclusive. 2 / 5

Patients with mental health or substance use disorders are at increased risk for nonmedical use and overdose from prescription painkillers as well as being prescribed high doses of these drugs, said CDC Director Tom Frieden, M.D., M.P.H. Appropriate screening, identification, and clinical management by health care providers are essential parts of both behavioral health and chronic pain management. Additional steps are being taken at the national, state and local levels, as well as by non-governmental organizations, to help prevent overdoses from prescription drugs. In particular, the federal government is: - Tracking prescription drug overdose trends to better understand the epidemic. 3 / 5

- Encouraging the development of abuse-deterrent opioid formulations and products that treat abuse and overdose. - Educating health care providers and the public about prescription drug abuse and overdose. - Requiring that manufacturers of extended-release and long-acting opioids make educational programs available to prescribers about the risks and benefits of opioid therapy, choosing patients appropriately, managing and monitoring patients, and counseling patients on the safe use of these drugs. - Using opioid labeling as a tool to inform prescribers and patients about the approved uses of these medications. - Developing, evaluating and promoting programs and policies shown to prevent prescription drug abuse and overdose, while making sure patients have access to safe, effective pain treatment. Promising steps that many states are taking include: - Starting or improving prescription drug monitoring programs, which are electronic databases that track all prescriptions for opioids in the state. - Using prescription drug monitoring programs, public insurance programs, and workers compensation data to identify improper prescribing of opioids. - Setting up programs for public insurance programs, workers compensation programs, and state-run health plans that identify and address improper patient use of opioids. 4 / 5

- Passing, enforcing and evaluating pill mill, doctor shopping and other state laws to reduce prescription opioid abuse. - Encouraging state licensing boards to take action against inappropriate prescribing. - Increasing access to substance abuse treatment. For more information about prescription drug overdoses in the United States, please visit www.cdc.gov/homeandrecreationalsafety/poisoni ng. Centers for Disease Control and Prevention (CDC), 20.02.2013 (tb). 5 / 5